EGFR
Les inhibiteurs du récepteur du facteur de croissance épidermique (EGFR) sont des composés qui bloquent la signalisation de l'EGFR, un récepteur souvent surexprimé dans divers cancers et qui joue un rôle crucial dans l'angiogenèse. Les inhibiteurs de l'EGFR sont utilisés pour prévenir la croissance tumorale et les métastases en perturbant les voies qui favorisent la formation de vaisseaux sanguins dans les tumeurs. Ces inhibiteurs sont largement utilisés dans la recherche et le traitement du cancer. Chez CymitQuimica, nous offrons une sélection diversifiée d'inhibiteurs de l'EGFR de haute qualité pour soutenir vos recherches en oncologie et angiogenèse.
587 produits trouvés pour "EGFR"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Butein
CAS :Formule :C15H12O5Degré de pureté :>98.0%(HPLC)Couleur et forme :Light yellow to Brown powder to crystalMasse moléculaire :272.26Genistein
CAS :Formule :C15H10O5Degré de pureté :>98.0%(HPLC)Couleur et forme :White to Light yellow to Light orange powder to crystalMasse moléculaire :270.24Lapatinib
CAS :Formule :C29H26ClFN4O4SDegré de pureté :>98.0%(T)(HPLC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :581.06Curcumin (Synthetic)
CAS :Formule :C21H20O6Degré de pureté :>97.0%(T)Couleur et forme :Light yellow to Brown powder to crystalMasse moléculaire :368.39Pelitinib
CAS :Formule :C24H23ClFN5O2Degré de pureté :>97.0%(HPLC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :467.93Tyrphostin A1
CAS :Formule :C11H8N2ODegré de pureté :>98.0%(GC)Couleur et forme :Light orange to Yellow to Green powder to crystalMasse moléculaire :184.20Erlotinib Hydrochloride
CAS :Formule :C22H23N3O4·HClDegré de pureté :>98.0%(T)(HPLC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :429.90Tyrphostin AG528
CAS :Formule :C18H14N2O3Degré de pureté :>97.0%(HPLC)Couleur et forme :Light yellow to Amber to Dark green powder to crystalMasse moléculaire :306.32Tyrphostin AG 835
CAS :Formule :C18H16N2O3Degré de pureté :>98.0%(HPLC)Couleur et forme :Light yellow to Amber to Dark green powder to crystalMasse moléculaire :308.34Neratinib
CAS :Formule :C30H29ClN6O3Degré de pureté :>95.0%(T)(HPLC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :557.05Methyl 2,5-Dihydroxycinnamate
CAS :Formule :C10H10O4Degré de pureté :>96.0%(HPLC)Couleur et forme :White to Yellow powder to crystalMasse moléculaire :194.19Tyrphostin A23
CAS :Formule :C10H6N2O2Degré de pureté :>98.0%(GC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :186.17PD 153035 Hydrochloride
CAS :Formule :C16H14BrN3O2·HClDegré de pureté :>97.0%(HPLC)Couleur et forme :White to Light yellow to Light orange powder to crystalMasse moléculaire :396.67Gefitinib
CAS :Formule :C22H24ClFN4O3Degré de pureté :>98.0%(T)(HPLC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :446.91Curcumin (Natural)
CAS :Formule :C21H20O6Couleur et forme :Light yellow to Brown powder to crystalMasse moléculaire :368.39Mevastatin
CAS :Mevastatin (ML236B) is an HMG-CoA reductase inhibitor that was initially isolated from the mold Pythium ultimum.Formule :C23H34O5Degré de pureté :99.12%Couleur et forme :White-Yellowish To Yellow Powder Solid PowderMasse moléculaire :390.51Intetumumab
CAS :Intetumumab (CNTO 95) is a fully humanized anti-α(v)-integrin monoclonal antibody that is a radiosensitizer for xenograft tumor-bearing mice.Degré de pureté :97.6% (SDS-PAGE); 97.1% (SEC-HPLC) - 97.6% (SDS-PAGE); 97.1% (SEC-HPLC)Couleur et forme :LiquidMasse moléculaire :145.56 kDa(2E)-2-Cyano-3-(3,4-dihydroxyphenyl)-N-[(1S)-1-phenylethyl]-2-propenamide
CAS :Formule :C18H16N2O3Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :308.3312Lapatinib
CAS :Lapatinib (GW572016) is an inhibitor of ErbB2 and EGFR (IC50=9.2/10.8 nM) with oral activity.Formule :C29H26ClFN4O4SDegré de pureté :99.00% - 99.81%Couleur et forme :PowderMasse moléculaire :581.06AG-528
CAS :Formule :C18H14N2O3Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :306.3154N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-(5-{[(2-methanesulfonylethyl)amino]methyl}furan-2-yl)quinazolin-4-amine
CAS :Formule :C29H26ClFN4O4SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :581.0575Ref: IN-DA0039KT
100gÀ demander250gÀ demander25mg29,00€100mg44,00€250mg56,00€1g106,00€5g222,00€50g573,00€Gefitinib
CAS :Gefitinib (ZD1839) is an EGFR first-generation inhibitor with oral activity that inhibits the EGFR 19 Del and L858R mutations.Formule :C22H24ClFN4O3Degré de pureté :99.92% - >99.99%Couleur et forme :Light-Yellow Crystalline PowderMasse moléculaire :446.90N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine
CAS :Formule :C22H24ClFN4O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :446.9024Propanedinitrile,2-[(4-methoxyphenyl)methylene]-
CAS :Formule :C11H8N2ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :184.1940Epertinib hydrochloride
CAS :Epertinib hydrochloride (S-22611 hydrochloride) shows potent antitumor activity.Formule :C30H28Cl2FN5O3Degré de pureté :99.14%Couleur et forme :SolidMasse moléculaire :596.48Ref: TM-T11213
1mg87,00€5mg178,00€1mL*10mM (DMSO)241,00€10mg295,00€25mg505,00€50mg715,00€100mg964,00€500mg1.935,00€Erlotinib
CAS :Erlotinib (NSC-718781) is an EGFR inhibitor (IC50: 2 nM). It is used for the treatment of non-small cell lung cancer.Formule :C22H23N3O4Degré de pureté :98.19% - 99.98%Couleur et forme :White To Off-White PowderMasse moléculaire :393.44Lapatinib Ditosylate
CAS :Lapatinib Ditosylate (Tykerb ditosylate) is an effective EGFR and ErbB2 inhibitor (IC50: 10.8/9.2 nM for EGFR/ErbB2).Formule :C29H26ClFN4O4S·2C7H8O3SDegré de pureté :99.41%Couleur et forme :Yellow SolidMasse moléculaire :925.46Petosemtamab
CAS :Petosemtamab (MCLA 158), a dual-action monoclonal antibody targets EGFR & LGR5, used in solid tumor research like HNSCC & CRC.
Degré de pureté :> 95% - > 95%Couleur et forme :LiquidMasse moléculaire :145.97 kDa(2E)-N-(4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide
CAS :Formule :C30H29ClN6O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :557.0427O-Desmethyl gefitinib
CAS :O-Desmethyl gefitinib is an active EGFR inhibitor (IC50: 36 nM), a metabolite of Gefitinib, formed by CYP2D6.Formule :C21H22ClFN4O3Degré de pureté :97.17%Couleur et forme :SolidMasse moléculaire :432.88Ref: TM-T16369
1mg52,00€5mg105,00€1mL*10mM (DMSO)114,00€10mg167,00€25mg324,00€50mg518,00€100mg742,00€(E)-N-benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide
CAS :Formule :C17H14N2O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :294.3047(2E)-2-Cyano-3-(3,5-di-tert-butyl-4-hydroxyphenyl)prop-2-enethioamide
CAS :Formule :C18H24N2OSDegré de pureté :95%Couleur et forme :SolidMasse moléculaire :316.46104H-1-Benzopyran-4-one, 5,7-dihydroxy-3-(4-hydroxyphenyl)-
CAS :Formule :C15H10O5Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :270.2369Ref: IN-DA00I8G3
5kgÀ demander10kgÀ demander5g24,00€1g26,00€100mg26,00€10g31,00€25g52,00€50g77,00€100g114,00€250g181,00€500g320,00€1kg686,00€Tyrphostin RG 14620
CAS :Formule :C14H8Cl2N2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :275.1327Lapatinib ditosylate monohydrate
CAS :Lapatinib ditosylate monohydrate: a drug for advanced breast cancer; may cause liver issues.
Formule :C29H26ClFN4O4S·2(C7H8O3S)·H2ODegré de pureté :98% - 99.41%Couleur et forme :Colourless To Light-Yellow CrystalMasse moléculaire :943.47AZ7550 hydrochloride
CAS :AZ7550 hydrochloride (AZ7550 hydrochloride ), an active metabolite of AZD9291, inhibits the activity of IGF1R (IC50: 1.6 μM).Formule :C27H32ClN7O2Degré de pureté :99.65%Couleur et forme :SolidMasse moléculaire :522.042-ButynaMide, N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]-
CAS :Formule :C18H13BrN4ODegré de pureté :97%Couleur et forme :SolidMasse moléculaire :381.2260Mutated EGFR-IN-1
CAS :Mutated EGFR-IN-1 (Osimertinib analog) is a useful intermediate for the inhibitors design for mutated EGFR, such as L858R EGFR, Exonl9 deletion activatingFormule :C25H31N7ODegré de pureté :98.91%Couleur et forme :SolidMasse moléculaire :445.562H-1-Benzopyran-2-one, 7,8-dihydroxy-
CAS :Formule :C9H6O4Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :178.1415WHI-P154
CAS :Formule :C16H14BrN3O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :376.20474-Quinazolinamine, N-(3-chlorophenyl)-6,7-dimethoxy-
CAS :Formule :C16H14ClN3O2Degré de pureté :99%Couleur et forme :SolidMasse moléculaire :315.7543Rociletinib
CAS :Rociletinib (CNX-419) is an orally available small molecule, irreversible inhibitor of epidermal growth factor receptor (EGFR) with potential antineoplasticFormule :C27H28F3N7O3Degré de pureté :98.52% - 99.25%Couleur et forme :SolidMasse moléculaire :555.55Erlotinib hydrochloride
CAS :Erlotinib hydrochloride (NSC 718781) is an EGFR inhibitor (IC50: 2 nM). It is used for the treatment of non-small cell lung cancer.Formule :C22H23N3O4·HClDegré de pureté :99.78% - 99.85%Couleur et forme :White Or Off-White PowderMasse moléculaire :429.90Panitumumab
CAS :Panitumumab is a fully human IgG2 monoclonal antibody targeting the epidermal growth factor receptor EGFR).Degré de pureté :95% - 98.1% (SDS-PAGE); 99.4% (SEC-HPLC)Couleur et forme :LiquidMasse moléculaire :144.31 kDaMethyl 2,5-Dihydroxycinnamate
CAS :Formule :C10H10O4Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :194.1840TYRPHOSTIN B48
CAS :Formule :C16H12N2O3Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :280.2781Allitinib
CAS :Allitinib (AST-1306) (AST-1306) has anti-cancer activity，and it is an irreversible EGFR and ErbB2 inhibitor with IC50s of 0.5 and 3 nM, respectively. [1]Formule :C24H18ClFN4O2Degré de pureté :99.89% - 99.91%Couleur et forme :SolidMasse moléculaire :448.88Ref: TM-T14336
1mg50,00€5mg105,00€1mL*10mM (DMSO)128,00€10mg172,00€25mg313,00€50mg467,00€100mg663,00€Tyrphostin RG 13022
CAS :Formule :C16H14N2O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :266.2946LCH-7749944
CAS :LCH-7749944 suppresses human gastric cancer cell growth, induces apoptosis, and inhibits PAK4 with IC50 of 14.93 μM.Formule :C20H22N4O2Degré de pureté :99.48%Couleur et forme :SolidMasse moléculaire :350.41Ref: TM-T11826
1mg50,00€5mg103,00€1mL*10mM (DMSO)110,00€10mg156,00€25mg269,00€50mg403,00€100mg583,00€200mg785,00€HyT36
CAS :HyT36: hydrophobic tag that destabilizes fusion proteins & Her3 pseudokinase; treats cells with acute erht.Formule :C25H44ClNO3Degré de pureté :99.02%Couleur et forme :SolidMasse moléculaire :442.07Ref: TM-T72075
1mg56,00€5mg119,00€1mL*10mM (DMSO)131,00€10mg188,00€25mg393,00€50mg628,00€100mg908,00€AV-412
CAS :AV-412 (MP412) is an EGFR inhibitor (EGFR, EGFR T790M, EGFR L858R, EGFR L858R/T790M and ErbB2 with IC50s of 0.75, 0.79, 0.5, 2.3, 19 nM).Formule :C41H44ClFN6O7S2Degré de pureté :99.85% - 99.92%Couleur et forme :SolidMasse moléculaire :851.41Ref: TM-T10419
1mg42,00€2mg55,00€5mg90,00€1mL*10mM (DMSO)129,00€10mg137,00€25mg240,00€50mg403,00€100mg582,00€Gancotamab
CAS :Gancotamab (MM-302) is a polyethylene glycolated liposome targeting HER2 with antitumor activity for the study of advanced HER2-positive breast cancer.Degré de pureté :96.7% (SDS-PAGE); 98.4% (SEC-HPLC) - 96.7% (SDS-PAGE); 98.4% (SEC-HPLC)Couleur et forme :LiquidMasse moléculaire :25.79 kDaPyrotinib dimaleate
CAS :Pyrotinib dimaleate is a selective EGFR/HER2 dual inhibitor, respectively, for the treatment of HER2-positive breast cancer.Cost-effective and quality-assured.Formule :C40H39ClN6O11Degré de pureté :97.27% - 99.52%Couleur et forme :SolidMasse moléculaire :815.22Ref: TM-T12594
1mg146,00€5mg434,00€10mg577,00€1mL*10mM (DMSO)587,00€25mg897,00€50mg1.234,00€100mg1.665,00€Khellin
CAS :Khellin (Methafrone) is a vasodilator that also has bronchodilatory action.Formule :C14H12O5Degré de pureté :99.89% - 99.95%Couleur et forme :Light Yellow CrystallineMasse moléculaire :260.241-[4-[4-[[2-[(1E)-2-[4-(Trifluoromethyl)phenyl]ethenyl]-4-oxazolyl]methoxy]phenyl]butyl]-1H-1,2,3-triazole
CAS :Formule :C25H23F3N4O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :468.4709Barecetamab
CAS :Barecetamab (ISU-104) is a humanized monoclonal antibody against tyrosine protein kinase ErbB3 with anticancer activity.Degré de pureté :97.1% (SDS-PAGE); 96.4% (SEC-HPLC) - 97.1% (SDS-PAGE); 96.4% (SEC-HPLC)Couleur et forme :LiquidMasse moléculaire :143.86 kDaBLU-945
CAS :BLU-945 is a reversible, potent, highly selective, and orally available epidermal growth factor receptor tyrosine kinase inhibitor (TKIs).Cost-effective and quality-assured.Formule :C28H37FN6O3SDegré de pureté :99.11% - 99.16%Couleur et forme :SolidMasse moléculaire :556.7Ref: TM-T9754
1mg35,00€5mg75,00€10mg114,00€25mg222,00€1mL*10mM (DMSO)241,00€50mg356,00€100mg557,00€200mg790,00€4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, hydrochloride (1:1)
CAS :Formule :C22H23ClN3O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :429.8967Dacomitinib metabolite M2
CAS :Dacomitinib metabolite M2 is also known as Dacomitinib cysteine conjugate. Dacomitinib inhibits both the wild-type (WT) EGFR and EGFR T790M.Formule :C27H32ClFN6O4SCouleur et forme :SolidMasse moléculaire :591.1EGFR T790M/L858R-IN-6
CAS :EGFR T790M/L858R-IN-6 (compound 53), classified as a pyrimidine compound, serves as an effective inhibitor of EGFR T790M/L858R, demonstrating 90.88% inhibition of enzyme activity at a concentration of 0.05 μM [1].Formule :C27H27N7O2Couleur et forme :SolidMasse moléculaire :481.55ZM 449829
CAS :ZM 449829: Selective JAK3 inhibitor, binds to ATP site. pIC50: 6.8 for JAK3, others < 5.0.Formule :C13H10ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :182.222PROTAC EGFR degrader 11
CAS :PROTAC EGFR degrader 11 (Compound B71) is a PROTAC degrader targeting the epidermal growth factor receptor (EGFR), with a DC50 of less than 100 nM. It binds to CRBN-DDB1 with a Ki of 36 nM. This compound effectively degrades EGFR, focal adhesion kinase (FAK), and RSK1, and inhibits the proliferation of BaF3 wild-type and EGFR mutant cells, exhibiting an IC50 of less than 100 nM.
Formule :C49H64ClFN10O7SCouleur et forme :SolidMasse moléculaire :991.61ErbB-2-binding peptide
CAS :ErbB-2-binding peptide (HER2-binding peptide), a tumor-targeting peptide, holds potential for cancer research applications [1].Formule :C43H60N8O11Couleur et forme :SolidMasse moléculaire :864.98SJF 1528
CAS :Potent EGFR & HER2 degrader; DC50 of 39.2 nM in OVCAR8, 736 nM in HeLa; has lapatinib, VHL ligand; inhibits HER2+ breast cancer (IC50=102 nM for SKBr3).Formule :C55H57ClFN7O8SCouleur et forme :SolidMasse moléculaire :1030.61PROTAC EGFR degrader 10
CAS :PROTAC EGF Rdegrader 10 (Compound B56) is a PROTAC degrader targeting the epidermal growth factor receptor (EGFR) with a DC50 of less than 100 nM. It binds to CRBN-DDB1 with a Ki of 37 nM and degrades EGFR, focal adhesion kinase (FAK), and RSK1, inhibiting the proliferation of BaF3 wild-type and EGFR mutants with an IC50 of less than 150 nM.Formule :C49H65ClN10O7SCouleur et forme :SolidMasse moléculaire :973.62EGFR/HER2-IN-15
EGFR/HER2-IN-15 is a dihydropyrimidine and an effective inhibitor of EGFR/HER2. It significantly suppresses EGFRwt activity with an IC50 of 37.21 nM and exhibits anticancer properties.Formule :C28H29N3O6Masse moléculaire :503.20564KRAS G12D inhibitor 25
CAS :KRAS G12D inhibitor 25 (Compound 148) acts as an inhibitor for KRAS G12C and HSP90α, displaying IC50 values of <0.1 μM and 0.1-1 μM respectively. Additionally, it suppresses the proliferation of MIA PaCa-2 and NCI-H358 cell lines, with EC50 values of <0.1 μM and 0.1-1 μM correspondingly. This compound also promotes the degradation of ERBB2, exhibiting a DC50 of 0.1-1 μM.Formule :C56H62ClN11O6Couleur et forme :SolidMasse moléculaire :1020.62HER2-IN-13
CAS :HER2-IN-13 (Compound 33) serves as an effective HER2 inhibitor, exhibiting an IC50 value of 8 nM, and additionally demonstrates inhibition of wt-EGFR with anFormule :C26H23ClF2N8O3Couleur et forme :SolidMasse moléculaire :568.96MS9449
CAS :MS9449 is a powerful EGFR PROTAC; Kd: 17 nM (WT), 10 nM (L858R); targets mutant EGFRs via UPS and autophagy; hinders NSCLC cell growth.Formule :C60H76ClFN10O8SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :1151.82DP-C-4
DP-C-4 is a Cereblon-based dual PROTAC for simultaneous degradation of EGFR and PARP[1].Couleur et forme :LiquidWAY-270360
CAS :WAY-270360 (N-[4-(1H-benzimidazol-2-yl)phenyl]-2,4-dimethoxybenzamide) is a sirtuin modulator and an epidermal growth factor receptor (EGFR) inhibitor.Formule :C22H19N3O3Degré de pureté :98.05%Couleur et forme :SolidMasse moléculaire :373.4JBJ-09-063 TFA
JBJ-09-063 TFA, an EGFR inhibitor selective for EGFR mutations, IC50s: 0.147-0.396 nM, blocks EGFR/Akt/ERK signaling, for EGFR-mutant lung cancer research.Formule :C33H30F4N4O5SCouleur et forme :SolidMasse moléculaire :670.67GW 583340
CAS :GW 583340 is a potent and selective dual inhibitor of EGFR/ErbB2 tyrosine kinase with the advantage of oral dosability and antitumor effects.Formule :C28H25ClFN5O3S2Degré de pureté :98.68%Couleur et forme :SoildMasse moléculaire :598.11EGFR-IN-93
EGFR-IN-93 (compound 18) is an allosteric inhibitor of the T790M/L858R double mutant EGFR. It is applicable for research in non-small cell lung cancer (NSCLC).Formule :C22H18FN3O3Masse moléculaire :391.13322HER2/neu (654-662) GP2
CAS :Phage display selected Affibody ligands for HER2/neu from a protein library based on a 58-residue Staphylococcal protein A Z domain.Formule :C42H77N9O11Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :884.11IBI-334
IBI-334 is a bispecific antibody targeting both B7-H3 and EGFR. It features an EGFR arm responsible for signal blocking, connected to a modified B7-H3 arm that ensures optimal affinity and binding. The antibody is afucosylated to enhance its antibody-dependent cellular cytotoxicity (ADCC) effects. IBI-334 is widely applicable in EGFR-driven solid tumors.Couleur et forme :Odour LiquidHerceptide
CAS :Herceptide (HER2-targeting peptide), a peptide that targets HER2, can be conjugated with the near-infrared fluorescent dye indocyanine green (ICG), facilitating the development of theranostic agents.Formule :C76H110N22O23Couleur et forme :SolidMasse moléculaire :1699.82HER2-IN-20
HER2-IN-20 (compound 32) is a potent and selective inhibitor of HER2WT and HER2YVMA, with IC50 values of 49 and 42 nM, respectively. It holds potential for research in non-small cell lung cancer (NSCLC).Formule :C30H27ClFN7O2Masse moléculaire :571.18988PRMT5/EGFR-IN-1
PRMT5/EGFR-IN-1 (Compound 10p) is an orally active dual inhibitor targeting PRMT5 and EGFR, with IC50 values of 15.47 μM and 19.31 μM, respectively. It demonstrates antiproliferative activity against the A549, MCF7, HeLa, and MDA-MB-231 cell lines. This compound also exhibits favorable pharmacokinetic (PK) and pharmacodynamic (PD) properties in vivo and significantly inhibits the growth of MCF7 orthotopic xenograft tumors.Formule :C27H22F6N2O2Masse moléculaire :520.15855CN009543V
CAS :CN009543V is an enhancer of tyrosine phosphorylation of EGFR via downstream signaling pathways.Formule :C12H12N4O6SCouleur et forme :SolidMasse moléculaire :340.31BMS-599626 2HCL(714971-09-2 Free base)
CAS :BMS-599626 2HCL (AC480 2HCl) is a BMS-599626 derivative.Formule :C27H29Cl2FN8O3Degré de pureté :99.11%Couleur et forme :Odour SolidMasse moléculaire :603.47EGFR-IN-43
EGFR-IN-43 (17c) is a potent EGFR inhibitor with ER antagonist action, tamoxifen/endoxifen+gefitinib linkage, and strong anticancer activity.Formule :C50H55ClFN5O5Couleur et forme :SolidMasse moléculaire :860.45MC-Val-Cit-PAB-Amide-TLR7 agonist 4
CAS :MC-Val-Cit-PAB-Amide-TLR7 agonist 4 Conjugate is a conjugate formed by linking MC-Val-Cit-PAB-Amide and TLR7 agonist 4, useful for cancer research.Formule :C52H72N12O11Degré de pureté :97.70%Couleur et forme :SolidMasse moléculaire :1041.2Gefitinib N-oxide hydrochloride
Gefitinib N-oxide hydrochloride is an N-oxide of EGFR inhibitor Gefitinib with IC50 of 2-37 nM.Formule :C22H24ClFN4O41·5HClCouleur et forme :SolidMasse moléculaire :517.59EGFR-IN-42
EGFR-IN-42 (17b) is a potent EGFR inhibitor with nanomolar efficacy, merging tamoxifen/endoxifen and gefitinib, exhibiting enhanced anti-cancer action.Formule :C49H53ClFN5O5Couleur et forme :SolidMasse moléculaire :846.43Lyso-Monosialoganglioside GM3
CAS :Lyso-Monosialoganglioside GM3 (Lyso-GM3) is an analog of Ganglioside GM3 with antitumor properties. It inhibits the increase in EGFR kinase activity induced by EGF in A431 epithelial cancer cells.Formule :C41H74N2O20Couleur et forme :SolidMasse moléculaire :915.028Inetetamab
Inetetamab is a recombinant humanized antibody targeting HER2 receptor domain IV, with anticancer activity, inducing pyroptosis in lung adenocarcinoma.Degré de pureté :96.54% (SEC-HPLC) - 96.54% (SEC-HPLC)Couleur et forme :Odour LiquidMasse moléculaire :145.1 kDaEGFR-IN-15
CAS :EGFR-IN-15 (compound I-005) is a potent EGFR inhibitor, exhibiting an IC50 value of 4 nM. This compound holds potential for oncological research applications.Formule :C24H25BrN6O2Couleur et forme :SolidMasse moléculaire :509.408JAK 3 inhibitor IV
CAS :JAK 3 inhibitor IV (ZM 39923 hydrochloride) is a JAK1/3 inhibitor with pIC50 of 4.4/7.1, almost no activity to JAK2 and modestly potent to EGFR; also found toFormule :C16H19NODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :241.33MS39N
CAS :MS39N (compound 27) serves as the negative control for MS39, capable of binding to EGFR without causing its degradation.Formule :C55H71ClFN9O7SMasse moléculaire :1056.73EGFR-IN-162
EGFR-IN-162 (compound 20) is an effective EGFR inhibitor that enhances both early and late apoptosis (EGFR) as well as necrosis (necrosis). It shows potential for use in breast cancer research.Formule :C27H31N3O2Couleur et forme :SolidMasse moléculaire :429.24163DSPE-PEG2000-GE11
DSPE-PEG2000-GE11 is a PEG compound composed of DSPE and an EGFR-targeting peptide (GE11). GE11 is applicable for cancer cells that overexpress EGFR. DSPE-PEG2000-GE11 is utilized in drug delivery.Couleur et forme :Odour SolidEGFR/PI3Kα-IN-1
EGFR/PI3Kα-IN-1 (compound 30k), a dual EGFR/PI3Kα inhibitor, exhibits potent activity with IC 50 values of 3.6 nM (EGFRL858R/T790M) and 30 nM (PI3Kα). It effectively inhibits tumor cell proliferation and demonstrates significant anticancer activity.Formule :C50H49N11O5SCouleur et forme :SolidMasse moléculaire :916.06DS06652923
DS06652923 is an orally active inhibitor targeting EGFR triple mutations. It exhibits growth-inhibitory effects on Ba/F3EGFRdel19/T90M/C795S cells, with a GI50 value of 9.4 nM. Additionally, DS06652923 induces tumor regression in the Ba/F3 syngeneic transplantation model.Couleur et forme :Odour SolidDepatuxizumab MMAF
Depatuxizumab-MMAF, an antibody-drug conjugate (ADC), comprises an EGFR-targeted antibody linked to McMMAF and is utilized in glioblastoma research.Couleur et forme :LiquidMasse moléculaire :148.24 kDaMS9427
CAS :MS9427: PROTAC EGFR degrader, 7.1 nM (WT), 4.3 nM (L858R); targets mutant via UPS and autophagy; inhibits NSCLC cell growth; anticancer research.Formule :C48H58ClFN8O12Couleur et forme :SolidMasse moléculaire :993.47EGFR-IN-22
CAS :EGFR-IN-22: potent for EGFR (IC50: 4.91 nM) & L858R/T790M/C797S mutation (IC50: 0.54 nM).Formule :C38H47BrFN10O2PCouleur et forme :SolidMasse moléculaire :805.72HER2-IN-14
CAS :HER2-IN-14 (Compound 34) is a potent inhibitor of HER2, achieving an inhibitory concentration (IC50) of 18 nM.Formule :C26H23ClF2N8O3Couleur et forme :SolidMasse moléculaire :568.96AG-1478 hydrochloride
CAS :AG1478 HCl is an epidermal growth factor receptor protein inhibitor.Formule :C16H15Cl2N3O2Couleur et forme :SolidMasse moléculaire :352.21
![(2E)-2-Cyano-3-(3,4-dihydroxyphenyl)-N-[(1S)-1-phenylethyl]-2-propenamide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA003988.webp&w=3840&q=75)
![N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-(5-{[(2-methanesulfonylethyl)amino]methyl}furan-2…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA0039KT.webp&w=3840&q=75)
![N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA0039KY.webp&w=3840&q=75)
![Propanedinitrile,2-[(4-methoxyphenyl)methylene]-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA007L0Q.webp&w=3840&q=75)
![(2E)-N-(4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimeth…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA0035DM.webp&w=3840&q=75)
![2-ButynaMide, N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00ABJJ.webp&w=3840&q=75)
![1-[4-[4-[[2-[(1E)-2-[4-(Trifluoromethyl)phenyl]ethenyl]-4-oxazolyl]methoxy]phenyl]butyl]-1H-1,2,3-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA0078T8.webp&w=3840&q=75)
